FUM vs. BVXP, TILS, VSN, HVO, MPH, SCLP, OBI, ORPH, REDX, and SBTX
Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Bioventix (BVXP), Tiziana Life Sciences (TILS), Verseon (VSN), hVIVO (HVO), Mereo BioPharma Group plc (MPH.L) (MPH), Scancell (SCLP), Ondine Biomedical (OBI), Open Orphan (ORPH), Redx Pharma (REDX), and SkinBioTherapeutics (SBTX). These companies are all part of the "biotechnology" industry.
Futura Medical vs.
Bioventix (LON:BVXP) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, community ranking, analyst recommendations, profitability and dividends.
Bioventix has a net margin of 59.51% compared to Futura Medical's net margin of -44.64%. Bioventix's return on equity of 69.09% beat Futura Medical's return on equity.
Bioventix has higher revenue and earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks.
62.3% of Bioventix shares are held by institutional investors. Comparatively, 35.7% of Futura Medical shares are held by institutional investors. 8.0% of Bioventix shares are held by insiders. Comparatively, 32.1% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Bioventix has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.
In the previous week, Bioventix had 3 more articles in the media than Futura Medical. MarketBeat recorded 3 mentions for Bioventix and 0 mentions for Futura Medical. Bioventix's average media sentiment score of 0.18 beat Futura Medical's score of 0.00 indicating that Bioventix is being referred to more favorably in the media.
Futura Medical received 94 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 64.36% of users gave Futura Medical an outperform vote while only 52.87% of users gave Bioventix an outperform vote.
Summary
Bioventix beats Futura Medical on 11 of the 15 factors compared between the two stocks.
Get Futura Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Futura Medical Competitors List
Related Companies and Tools
This page (LON:FUM) was last updated on 4/2/2025 by MarketBeat.com Staff
Buy FUM Stock Free FUM Stock Alerts